SecBot SecBot
SC 13G ·Filed Nov 10, 2026

SRPT

Sarepta Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6d 16h ago SEC0000093751-26-000721
Passive investor 5%+ stake
Actionable Insight • Neutral

State Street's passive 7.4% stake is consistent with index fund and institutional ownership patterns. Monitor the next 13F filing for any material changes in position size, and watch for any future 13D conversion if State Street's investment approach shifts.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$16.42
T+0 close · Nov 10, 2026 · via day close
Latest settled
+1.58%
T+1 · $16.68
Vs SPY
+0.26%
α at T+1
Next horizon
T+5
in 5h
  1. T+0 · Nov 10 $16.42entry
  2. T+1 · 6d ago +1.58%α +0.26% · $16.68
  3. T+4 · todayOpen
  4. T+5 · in 5h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corp filed a new Schedule 13G disclosing a 7.4% passive stake in Sarepta Therapeutics as of September 30, 2026. This follows State Street's prior 13G filing in August 2026 and comes five days after Sarepta raised its full-year revenue guidance. The filing confirms a passive investment intent with no control-related purpose.

Key Financial Metrics

Stake
7.4%
Investor
STATE STREET CORP

Key Facts

  • State Street Corp filed a new Schedule 13G on November 10, 2026, disclosing beneficial ownership of 7,412,275 shares of Sarepta Therapeutics common stock as of September 30, 2026.
  • The stake represents approximately 7.4% of shares outstanding based on the 7,412,275 shares reported.
  • State Street certifies the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.
  • This filing follows State Street's prior 13G filing on August 7, 2026, indicating a continued passive position.
  • The filing comes five days after Sarepta raised its full-year net product revenue guidance to $1.25B-$1.3B on November 5, 2026.

Financial Impact

State Street holds 7,412,275 shares; at a $1.9B market cap this stake is valued at approximately $140M.

ownership

Risk Factors

  • No activist intent is indicated; the filing explicitly certifies passive investment purpose.
  • The stake size is moderate for an institutional holder and does not signal unusual conviction beyond normal portfolio allocation.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
39% bullish (31 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000721
Document: 0000093751-26-000721-index.html0000093751-26-000721
Document: 0000093751-26-000721.txt0000093751-26-000721

US Market Status

Market Closed · Opens in 7h 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026